Histatin 5
Histatin 5 is a 24-amino acid histidine-rich salivary antimicrobial peptide with potent antifungal activity against Candida albicans, acting through a unique mitochondrial targeting mechanism distinct from membrane disruption.
Histatin 5 is a 24-amino acid histidine-rich cationic antimicrobial peptide found in human saliva, secreted by the parotid and submandibular salivary glands. It is the most potent antifungal member of the histatin family (histatins 1–12), a group of peptides unique to humans and higher primates.
Overview
The histatins were first identified by Oppenheim et al. in 1986 as a family of histidine-rich polypeptides in human parotid secretion Oppenheim et al. (1986). Histatins 1 and 3 are gene products of HTN1 and HTN3 respectively, while histatin 5 is generated by post-secretory proteolytic cleavage of histatin 3. The family is characterized by an unusually high histidine content (~25%) and is found exclusively in the saliva of humans and Old World primates.
Histatin 5 serves multiple protective functions in the oral cavity: antimicrobial defense (particularly antifungal), wound healing promotion, inhibition of bacterial co-aggregation, and maintenance of oral mucosal integrity. Its antifungal potency is clinically relevant — histatin 5 kills >90% of C. albicans blastospores at physiological salivary concentrations within 30 minutes, making it a primary defense against oral candidiasis.
The connection between histatin deficiency and fungal infection is evident in xerostomia (dry mouth) patients, who have reduced salivary histatin levels and dramatically increased susceptibility to oral candidiasis. This clinical correlation underscores the non-redundant role of histatins in oral antifungal defense.
Mechanism of Action
Histatin 5's antifungal mechanism is distinctly non-lytic and involves active internalization:
- Binding to fungal cell wall: Histatin 5 initially binds to cell wall components of C. albicans, including the heat shock protein Ssa2 (a surface-exposed member of the Hsp70 family) and cell wall beta-glucans. Ssa2 binding is required for efficient killing — SSA2 deletion mutants show significantly reduced histatin 5 susceptibility Li et al. (2003).
- Active translocation via Dur3: Histatin 5 is actively transported into C. albicans cells through the polyamine transporter Dur3p. This energy-dependent internalization distinguishes histatin 5 from membrane-lytic antimicrobial peptides and explains why metabolically active cells are more susceptible than resting cells Kumar et al. (2011).
- Mitochondrial targeting: Once internalized, histatin 5 localizes to mitochondria and disrupts mitochondrial membrane potential (ΔΨm), leading to generation of reactive oxygen species (ROS), release of ATP, and loss of mitochondrial function. This mitochondrial targeting is a key component of the killing mechanism Helmerhorst et al. (2001).
- Ion imbalance and volume dysregulation: Histatin 5 causes release of intracellular potassium and ATP, leading to osmotic stress and cell volume loss. This is accompanied by activation of the Trk1 potassium transporter as a compensatory mechanism Baev et al. (2004).
- Non-lytic cell death: Unlike membrane-disrupting antimicrobial peptides, histatin 5 kills C. albicans without gross membrane lysis. Cells treated with histatin 5 maintain membrane integrity (as measured by propidium iodide exclusion) while losing metabolic viability, indicating an intracellular killing mechanism.
Reconstitution Calculator
Reconstitution Calculator
Calculate your peptide dosing
Set up a clean workspace with all supplies ready.
7x / week for weeks
Research
Anti-Candida Activity
Histatin 5 is the most potent naturally occurring antifungal peptide in human saliva. It kills C. albicans, C. glabrata, C. krusei, and Cryptococcus neoformans at concentrations of 15–30 μM, well within the range found in normal human saliva. Killing is rapid (50% kill within 5–10 minutes) and concentration-dependent. Edgerton et al. showed that histatin 5 also kills azole-resistant Candida strains, as its mechanism (mitochondrial targeting) is entirely independent of the ergosterol biosynthesis pathway targeted by azole and polyene antifungals Edgerton et al. (1998).
Mitochondrial Targeting Mechanism
The discovery that histatin 5 targets fungal mitochondria was made by Helmerhorst et al. (2001), who showed that histatin 5 causes rapid loss of mitochondrial transmembrane potential in C. albicans and that cells with non-functional mitochondria (petite mutants) are resistant to killing. Fluorescently labeled histatin 5 localizes to mitochondria within minutes of internalization. This mechanism is unique among antimicrobial peptides and shares more similarity with certain antifungal drugs (amphotericin B) than with membrane-lytic antimicrobial peptides Helmerhorst et al. (2001).
Oral Health and Innate Immunity
Histatins constitute approximately 2.6% of total salivary protein and are essential components of the oral innate immune system. Beyond antifungal activity, histatin 5 inhibits bacterial co-aggregation (a key step in dental plaque formation), binds tannins (preventing mucosal damage from dietary polyphenols), and participates in the formation of the acquired enamel pellicle that protects tooth surfaces Tsai & Bobek (1998).
Wound Healing Promotion
Histatins promote wound healing — a property first recognized from the clinical observation that oral wounds heal faster than skin wounds of comparable severity. Oudhoff et al. demonstrated that histatin 1 (and to a lesser extent histatin 5) promotes epithelial cell migration and wound closure in vitro through activation of the ERK1/2 signaling pathway and the G-protein-coupled receptor GPR120. This wound healing activity is independent of the antimicrobial function Oudhoff et al. (2008).
P-113: Truncated Histatin 5 Analog
P-113 (demegen, PAC-113) is a 12-amino acid truncated analog of histatin 5 (residues 4–15) that retains full antifungal activity with improved stability. P-113 completed Phase II clinical trials as an oral rinse for HIV-associated oral candidiasis, showing dose-dependent reduction in Candida colony counts. It represents one of the few antimicrobial peptide-derived drugs to advance to clinical testing Rothstein et al. (2001).
Xerostomia and Clinical Implications
Xerostomia (dry mouth), whether caused by Sjogren's syndrome, radiation therapy, or medication side effects, results in dramatically reduced salivary flow and histatin concentrations. The consequent loss of histatin-mediated antifungal defense is a primary factor in the high prevalence of oral candidiasis in xerostomic patients (up to 70% compared to <5% in healthy individuals). This clinical correlation validates the essential role of histatins in oral antifungal defense and has motivated research into histatin-based prophylactic formulations for at-risk patients Jainkittivong et al. (2009).
Safety Profile
Histatin 5 has an excellent safety profile consistent with its nature as an endogenous salivary peptide:
- Constitutive presence: Histatin 5 is naturally present in saliva at 15–30 μM concentrations throughout life, with no associated toxicity.
- Low cytotoxicity: Histatin 5 shows minimal toxicity to mammalian cells at antifungal concentrations, with LC₅₀ values for human epithelial cells exceeding 200 μM — an order of magnitude above the effective antifungal concentration.
- Selectivity mechanism: The requirement for active internalization via the Dur3 polyamine transporter (present in fungi but not mammalian cells) provides inherent selectivity for fungal targets.
- P-113 clinical safety: In Phase I/II clinical trials, P-113 oral rinse was well-tolerated with no serious adverse events. Taste alteration was the most common side effect.
- No hemolytic activity: Histatin 5 shows no hemolytic activity at concentrations up to 500 μM, consistent with its non-lytic mechanism of action.
- Protease susceptibility: Histatin 5 is degraded by C. albicans secreted aspartyl proteases (Saps), which may reduce efficacy in heavily infected environments. This represents a natural resistance mechanism rather than a safety concern.
Pharmacokinetic Profile
Histatin 5 — Pharmacokinetic Curve
Molecular Structure
- Formula
- C₁₃₇H₂₀₃N₄₇O₃₅
- Weight
- 3036.3 Da
- PubChem CID
- 71308633
- Exact Mass
- 3035.5182 Da
- LogP
- -18.7
- TPSA
- 1380 Ų
- H-Bond Donors
- 51
- H-Bond Acceptors
- 48
- Rotatable Bonds
- 105
- Complexity
- 6770
Identifiers (SMILES, InChI)
InChI=1S/C133H195N51O33/c1-71(164-120(206)96(46-76-54-146-65-158-76)181-128(214)103(62-185)183-110(196)84(138)52-108(193)194)109(195)167-86(18-5-9-35-134)113(199)172-91(24-15-41-154-133(143)144)118(204)178-99(49-79-57-149-68-161-79)125(211)176-95(45-75-53-145-64-157-75)112(198)156-60-105(189)165-93(43-73-25-29-82(187)30-26-73)121(207)173-87(19-6-10-36-135)114(200)171-90(23-14-40-153-132(141)142)115(201)169-88(20-7-11-37-136)116(202)175-94(42-72-16-3-2-4-17-72)122(208)179-97(47-77-55-147-66-159-77)124(210)174-92(33-34-107(191)192)119(205)170-89(21-8-12-38-137)117(203)177-100(50-80-58-150-69-162-80)126(212)180-101(51-81-59-151-70-163-81)127(213)184-104(63-186)129(215)182-98(48-78-56-148-67-160-78)123(209)168-85(22-13-39-152-131(139)140)111(197)155-61-106(190)166-102(130(216)217)44-74-27-31-83(188)32-28-74/h2-4,16-17,25-32,53-59,64-71,84-104,185-188H,5-15,18-24,33-52,60-63,134-138H2,1H3,(H,145,157)(H,146,158)(H,147,159)(H,148,160)(H,149,161)(H,150,162)(H,151,163)(H,155,197)(H,156,198)(H,164,206)(H,165,189)(H,166,190)(H,167,195)(H,168,209)(H,169,201)(H,170,205)(H,171,200)(H,172,199)(H,173,207)(H,174,210)(H,175,202)(H,176,211)(H,177,203)(H,178,204)(H,179,208)(H,180,212)(H,181,214)(H,182,215)(H,183,196)(H,184,213)(H,191,192)(H,193,194)(H,216,217)(H4,139,140,152)(H4,141,142,153)(H4,143,144,154)/t71-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-/m0/s1
KSXBMTJGDUPBBN-VPKNIDFUSA-NResearch Indications
Antimicrobial
Histatin 5 is the most potent antifungal peptide in human saliva. It kills Candida albicans through a non-lytic mechanism involving mitochondrial targeting and generation of reactive oxygen species. Reduced salivary histatin correlates with oral candidiasis risk.
Active against multiple Candida species (C. albicans, C. glabrata, C. krusei) and Cryptococcus neoformans. Mechanism involves binding to fungal cell wall protein Ssa2 and intracellular targeting of mitochondria.
Histatin 5 helps maintain healthy oral microbial balance. Patients with reduced salivary histatins (Sjogren syndrome, HIV, radiation therapy) show increased susceptibility to oral fungal infections.
Wound Healing
Histatin 5 and related histatins promote oral wound healing by stimulating cell migration and spreading. Oral wounds heal faster than skin wounds partly due to salivary histatin content.
Promotes keratinocyte and epithelial cell migration through activation of G-protein coupled signaling and ERK1/2 phosphorylation, contributing to wound closure independent of proliferation.
Research Protocols
oral
Histatin 5 serves multiple protective functions in the oral cavity: antimicrobial defense (particularly antifungal), wound healing promotion, inhibition of bacterial co-aggregation, and maintenance of oral mucosal integrity. albicans* blastospores at physiological salivary concentrations within 30 m
Interactions
Peptide Interactions
Histatin 5 is a His-rich, Zn(II)-binding peptide whose antifungal activity is enhanced by zinc interactions. Zinc binds to histidine residues and stabilizes bioactive conformations, while copper and zinc sites are distinct. Loss of metal specificity and conformational destabilization decrease antimicrobial activity. Source: Puri & Bhatt, Sci Rep 2019.
What to Expect
What to Expect
Rapid onset expected; half-life of ~30–60 minutes in saliva indicates fast-acting pharmacokinetics
Killing is rapid (50% kill within 5–10 minutes) and concentration-dependent.
Due to short half-life (~30–60 minutes in saliva), effects are expected per-dose; consistent daily administration maintains therapeutic levels
Regular administration schedule required; effects are dose-dependent and do not persist between doses
Quality Indicators
What to look for
- Well-established safety profile
- Naturally occurring compound
- Extensive peer-reviewed research base
Red flags
- Significant side effect risk noted
Frequently Asked Questions
References (14)
- [1]Oppenheim FG, Xu T, McMillian FM, et al Histatins, a novel family of histidine-rich proteins in human parotid secretion J Biol Chem (1988)
- [12]Khan SA et al — Salivary antimicrobial peptides in oral health and disease: current perspectives Arch Oral Biol (2024)
- [14]Xu Y et al — Histatin-derived peptides as templates for antifungal drug design Antimicrob Agents Chemother (2023)
- [10]Jainkittivong A, Aneksuk V, Langlais RP Oral mucosal conditions in elderly dental patients Oral Dis (2009)
- [2]Edgerton M, Koshlukova SE, Lo TE, et al Candidacidal activity of salivary histatins J Biol Chem (1998)
- [6]Baev D, Li XS, Dong J, et al Human salivary histatin 5 causes disordered volume regulation and cell cycle arrest in Candida albicans Infect Immun (2004)
- [8]Tsai H, Bobek LA Human salivary histatins: promising anti-fungal therapeutic agents Crit Rev Oral Biol Med (1998)
- [9]Rothstein DM, Spacciapoli P, Tran LT, et al Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5 Antimicrob Agents Chemother (2001)
- [3]Helmerhorst EJ, Breeuwer P, van't Hof W, et al The cellular target of histatin 5 on Candida albicans is the energized mitochondrion J Biol Chem (2001)
- [4]Li XS, Reddy MS, Baev D, Edgerton M Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5 J Biol Chem (2003)
- [7]Oudhoff MJ, Bolscher JG, Nazmi K, et al Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay FASEB J (2008)
- [11]
- [5]Kumar R, Chadha S, Saraswat D, et al Histatin 5 uptake by Candida albicans utilizes the cell-surface protein Ssa2 J Biol Chem (2011)
- [13]Norris HL et al — Fungal-host interactions in oral candidiasis: role of salivary antimicrobial peptides PLoS Pathog (2022)
Hexarelin
Hexarelin is a synthetic hexapeptide growth hormone secretagogue and ghrelin analogue with potent cardioprotective effects, muscle-preserving properties, and lipid metabolism benefits.
HMG (Human Menopausal Gonadotropin)
Human Menopausal Gonadotropin (hMG/Menotropins) is a combination of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) extracted from postmenopausal urine, used clinically for ovulation induction in IVF and treatment of male hypogonadotropic hypogonadism.